πŸ† Finalist β€” NIH Data Sharing Index (β€œS-Index”) Challenge

Michael R. McLaren

Akebia Therapeutics (United States)

ORCID: 0000-0003-1575-473X

Also affiliated with Massachusetts Institute of Technology

Biochemistry, Genetics and Molecular BiologyMedicineEnvironmental Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β€” papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6Β· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: β€œClostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota”.

196 citations

Colleen M. Pike, Ruth Parsons, Alissa J. Rivera, Matthew H. Foley, Michael R. McLaren +3 more

4 citations

Colleen M. Pike, Ruth Parsons, Alissa J. Rivera, Matthew H. Foley, Michael R. McLaren +3 more

17 citations

Michael R. McLaren, Alissa J. Rivera, A.D. Reed, Naga S. Betrapally, T. Burdette +5 more

N/A
0DataRank Β· unranked
25 citations

Jacob T. Nearing, Amy D. Willis, Karen G. Lloyd, Benjamin J. Callahan, Michael R. McLaren